Brainstorm Cell diskutieren
Brainstorm Cell
WKN: A12BXW / Symbol: BCLI / Name: Brainstorm Cell / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,44 €
19,62 %
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) had its price target raised by analysts at Maxim Group from $5.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for BCLI provided by MarketBeat
Neueste Beiträge
Truist_Financial_Co_ in Curis Inc. diskutieren